Regulacje i polityka gospodarcza · 06/09/2019

HRSA Submits 340B Drug Pricing Program Reporting Requirements for OMB Review and Approval

HRSA is seeking public comment on its proposed collection of data for the 340B Drug Pricing Program, as required by the Paperwork Reduction Act of 1995, and is submitting the request to the Office of Management and Budget (OMB) for review and approval.